{"schema_version":"secwatch.filing_event.v1","accession":"0001944048-24-000150","form_type":"8-K","ticker":"KVUE","cik":"0001944048","company_name":"Kenvue Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.398997+00:00","generated_at":"2026-05-30T03:57:01.573221+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kenvue Q3 net sales -0.4% to $3.9B, adj EPS $0.28 vs $0.31 YoY, lowers sales growth guidance","bullets":["Net sales $3.9B, -0.4% YoY; organic growth +0.9% (value realization +2.5%, volume -1.6%).","Diluted EPS $0.20; adjusted diluted EPS $0.28 vs $0.31 YoY; gross margin expanded 100bps to 58.5%.","Self Care drove share gains; Essential Health broad-based growth; Skin Health and Beauty early recovery signs.","2024 outlook: net sales & organic growth guidance lowered to low end of ranges (1-3% & 2-4%); adj EPS reaffirmed $1.10-$1.20.","Adjusted operating margin 22.1% vs 23.3% YoY due to increased brand investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001944048-24-000150","json":"https://secwatch.observer/filing/0001944048-24-000150.json","markdown":"https://secwatch.observer/filing/0001944048-24-000150.md","text":"https://secwatch.observer/filing/0001944048-24-000150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1944048/000194404824000150/0001944048-24-000150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1944048/000194404824000150/kvue-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:57:01.573221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}